|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
This article has been cited by other articles:
![]() |
F. Marongiu, S. Doratiotto, S. Montisci, P. Pani, and E. Laconi Liver Repopulation and Carcinogenesis: Two Sides of the Same Coin? Am. J. Pathol., April 1, 2008; 172(4): 857 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lahlou, M. Fanjul, L. Pradayrol, C. Susini, and S. Pyronnet Restoration of Functional Gap Junctions through Internal Ribosome Entry Site-Dependent Synthesis of Endogenous Connexins in Density-Inhibited Cancer Cells Mol. Cell. Biol., May 15, 2005; 25(10): 4034 - 4045. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Leithe, V. Cruciani, T. Sanner, S.-O. Mikalsen, and E. Rivedal Recovery of gap junctional intercellular communication after phorbol ester treatment requires proteasomal degradation of protein kinase C Carcinogenesis, July 1, 2003; 24(7): 1239 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Viluksela, Y. Bager, J. T. Tuomisto, G. Scheu, M. Unkila, R. Pohjanvirta, S. Flodström, V.-M. Kosma, J. Mäki-Paakkanen, T. Vartiainen, et al. Liver Tumor-promoting Activity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant Rat Strains Cancer Res., December 1, 2000; 60(24): 6911 - 6920. [Abstract] [Full Text] |
||||
![]() |
A. Low-Baselli, W. W. Huber, M. Kafer, K. Bukowska, R. Schulte-Hermann, and B. Grasl-Kraupp Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note Carcinogenesis, October 1, 2000; 21(10): 1869 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Jeong, S. S. M. Habeebu, and C. D. Klaassen Cadmium Decreases Gap Junctional Intercellular Communication in Mouse Liver Toxicol. Sci., September 1, 2000; 57(1): 156 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Moennikes, A. Buchmann, A. Romualdi, T. Ott, J. Werringloer, K. Willecke, and M. Schwarz Lack of Phenobarbital-mediated Promotion of Hepatocarcinogenesis in Connexin32-Null Mice Cancer Res., September 1, 2000; 60(18): 5087 - 5091. [Abstract] [Full Text] |
||||
![]() |
T. Shoda, H. Onodera, M. Takeda, C. Uneyama, T. Imazawa, K. Takegawa, K. Yasuhara, T. Watanabe, M. Hirose, and K. Mitsumori Liver Tumor Promoting Effects of Fenbendazole in Rats Toxicol Pathol, September 1, 1999; 27(5): 553 - 562. [Abstract] [PDF] |
||||
![]() |
O. Moennikes, A. Buchmann, T. Ott, K. Willecke1, and M. Schwarz2 The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains Carcinogenesis, July 1, 1999; 20(7): 1379 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Piechocki, R. D. Burk, and R. J. Ruch Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells Carcinogenesis, March 1, 1999; 20(3): 401 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Bevans, M. Kordel, S. K. Rhee, and A. L. Harris Isoform Composition of Connexin Channels Determines Selectivity among Second Messengers and Uncharged Molecules J. Biol. Chem., January 30, 1998; 273(5): 2808 - 2816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.K. Chipman Connexin genes as tumour suppressor genes? Altered homologous and heterologous gap-junc tional intercellular communication in primary human liver tumors associated with aberrant pro tein localization but not gene mutation of connexin 32. Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon A-M, Mesnil M, Berger F, Partensky C and Yamasaki H. International Journal of Cancer: 1994; 56: 87-94 Human and Experimental Toxicology, June 1, 1995; 14(6): 539 - 540. [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||